Antiretroviral Strategies to Prevent Mother-to-Child Transmission of HIV: Striking a Balance between Efficacy, Feasibility, and Resistance
Authors:
Open Access
- 27 October 2009
- journal article
- editorial
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 6 (10) , e1000169
Abstract
Dara Lehman and colleagues discuss a randomized trial that found that adding up to a week of twice-daily zidovudine+lamivudine to single-dose nevirapine reduces the risk of resistance in mothers and infants.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical TrialPLOS Medicine, 2009
- Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Prevention of mother-to-child transmission, drug resistance, and implications for response to therapyCurrent Opinion in HIV and AIDS, 2008
- Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settingsCurrent Opinion in HIV and AIDS, 2008
- International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 updateAmerican Journal of Obstetrics and Gynecology, 2007
- Response to Antiretroviral Therapy after a Single, Peripartum Dose of NevirapineNew England Journal of Medicine, 2007
- Low Risk of Nevirapine Resistance Mutations in the Prevention of Mother‐to‐Child Transmission of HIV‐1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Côte d’IvoireThe Journal of Infectious Diseases, 2006
- Development of Nevirapine Resistance in Infants Is Reduced by Use of Infant‐Only Single‐Dose Nevirapine plus Zidovudine Postexposure Prophylaxis for the Prevention of Mother‐to‐Child Transmission of HIV‐1The Journal of Infectious Diseases, 2006
- Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral TherapyNew England Journal of Medicine, 2004
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999